Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eric T. Hansen is active.

Publication


Featured researches published by Eric T. Hansen.


Transfusion | 2005

Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes : possible implications for the role of glucose in platelet storage

Junzhi Li; Laura Goodrich; Eric T. Hansen; Rick Edrich; Deanna Gampp; Raymond P. Goodrich

BACKGROUND:  Stress‐enhanced platelet (PLT) storage lesions include increased glycolysis, discoid‐to‐sphere morphology change, and spontaneous PLT activation. It is not clear if reduction in glycolysis can alleviate storage lesion development.


Biochemical and Biophysical Research Communications | 2008

Reduction of Prion Infectivity in Packed Red Blood Cells

Rodrigo Morales; Kimberley A. Buytaert-Hoefen; Dennisse Gonzalez-Romero; Joaquín Castilla; Eric T. Hansen; Dennis J. Hlavinka; Raymond P. Goodrich; Claudio Soto

The link between a new variant form of Creutzfeldt-Jakob disease (vCJD) and the consumption of prion contaminated cattle meat as well as recent findings showing that vCJD can be transmitted by blood transfusion have raised public health concerns. Currently, a reliable test to identify prions in blood samples is not available. The purpose of this study was to evaluate the possibility to remove scrapie prion protein (PrP(Sc)) and infectivity from red blood cell (RBC) suspensions by a simple washing procedure using a cell separation and washing device. The extent of prion removal was assessed by Western blot, PMCA and infectivity bioassays. Our results revealed a substantial removal of infectious prions (3 logs of infectivity) by all techniques used. These data suggest that a significant amount of infectivity present in RBC preparations can be removed by a simple washing procedure. This technology may lead to increased safety of blood products and reduce the risk of further propagation of prion diseases.


Archive | 2006

Chapter 5:The Antiviral and Antibacterial Properties of Riboflavin and Light: Applications To Blood Safety and Transfusion Medicine

Raymond P. Goodrich; Richard A. Edrich; Laura Goodrich; Cynthia A. Scott; Keith Manica; Dennis J. Hlavinka; Nick Hovenga; Eric T. Hansen; Deanna Gampp; Shawn D. Keil; Denise Gilmour; Junzhi Li; Christopher Blake Martin; Matthew S. Platz

In the developed world, blood products are extensively tested for the presence of pathogens prior to administration. Nevertheless, there exists a small, but finite risk of transmission of infectious agents in transfusion medicine.1 The risks of viral infection are due to the “window period”; the per...


Archive | 2007

Apparatus and method for separating volumes of a composite liquid with a balancing assembly

Dennis J. Hlavinka; Eric T. Hansen


Archive | 2007

Methods for washing a red blood cell component and for removing prions therefrom

Dennis J. Hlavinka; Raymond P. Goodrich; Eric T. Hansen


Journal of Clinical Oncology | 2017

Prognostic value of the absolute lymphocyte to monocyte (ALC/AMC) ratio on overall survival among patients with mantle cell lymphoma.

Andre Goy; Tatyana Feldman; Lori Ann Leslie; Alan P Skarbnik; Tommy Wu; Eric T. Hansen; Srikesh Arunajadai; Ewelina A Protomastro; Marisa Valentinetti; Judy L. Smith; Kelly Choi


Blood | 2016

Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)

Andre Goy; Tommy Wu; Eric T. Hansen; Srikesh Arunajadai; Ewelina A Protomastro; Marisa Valentinetti; Maureen Murphy; Judith Smith; Ruth Pe Benito; Ali Hasan; Kiran Suryadevara; Tatyana Feldman; Alan P Skarbnik; Lori Ann Leslie; Scott D. Rowley; Michele L. Donato; Andrew L. Pecora; Stuart L. Goldberg


Archive | 2007

Procédés pour laver un composant de globule rouge, et pour retirer des prions de celui-ci

Dennis J. Hlavinka; Raymond P. Goodrich; Eric T. Hansen


Archive | 2007

METHODS AND COMPOSITIONS FOR THE PRODUCTION OF HIGH CONCENTRATION ALLOXAZINE SOLUTIONS

Eric T. Hansen; Raymond P. Goodrich


Archive | 2007

Composition for treating a blood product with a concentration alloxazine solution

Eric T. Hansen; Raymond P. Goodrich

Collaboration


Dive into the Eric T. Hansen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dennis J. Hlavinka

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Alan P Skarbnik

Hackensack University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Andre Goy

Hackensack University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Claudio Soto

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Ewelina A Protomastro

Hackensack University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kimberley A. Buytaert-Hoefen

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Lori Ann Leslie

Hackensack University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Marisa Valentinetti

Hackensack University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rodrigo Morales

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge